Literature DB >> 29844046

Recommendations To Address the Difficulties Encountered When Determining Linezolid Resistance from Whole-Genome Sequencing Data.

Alicia G Beukers1, Henrik Hasman2, Kristin Hegstad3,4, Sebastiaan J van Hal5.   

Abstract

Mutations associated with linezolid resistance within the V domain of 23S rRNA are annotated using an Escherichia coli numbering system. The 23S rRNA gene varies in length, nucleotide sequence, and copy number among bacterial species. Consequently, this numbering system is not intuitive and can lead to confusion when mutation sites are being located using whole-genome sequencing data. Using the mutation G2576T as an example, we demonstrate the difficulties associated with using the E. coli numbering system. © Crown copyright 2018.

Entities:  

Keywords:  G2576T; linezolid resistance; whole-genome sequencing

Mesh:

Substances:

Year:  2018        PMID: 29844046      PMCID: PMC6105777          DOI: 10.1128/AAC.00613-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

Review 1.  Resistance to linezolid caused by modifications at its binding site on the ribosome.

Authors:  Katherine S Long; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  S H Marshall; C J Donskey; R Hutton-Thomas; R A Salata; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

3.  Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.

Authors:  Silke Besier; Albrecht Ludwig; Johannes Zander; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

Review 4.  Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.

Authors:  Paul W Ament; Namirah Jamshed; John P Horne
Journal:  Am Fam Physician       Date:  2002-02-15       Impact factor: 3.292

5.  Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.

Authors:  Michael Lobritz; Rebecca Hutton-Thomas; Steve Marshall; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

  5 in total
  4 in total

1.  The global dissemination of hospital clones of Enterococcus faecium.

Authors:  Sebastiaan J van Hal; Rob J L Willems; Theodore Gouliouris; Susan A Ballard; Teresa M Coque; Anette M Hammerum; Kristin Hegstad; Hendrik T Westh; Benjamin P Howden; Surbhi Malhotra-Kumar; Guido Werner; Katsunori Yanagihara; Ashlee M Earl; Katherine E Raven; Jukka Corander; Rory Bowden
Journal:  Genome Med       Date:  2021-03-30       Impact factor: 11.117

2.  Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States.

Authors:  Amy S Gargis; Lori M Spicer; Alyssa G Kent; Wenming Zhu; Davina Campbell; Gillian McAllister; Thomas O Ewing; Valerie Albrecht; Valerie A Stevens; Mili Sheth; Jasmine Padilla; Dhwani Batra; J Kristie Johnson; Alison Laufer Halpin; J Kamile Rasheed; Christopher A Elkins; Maria Karlsson; Joseph D Lutgring
Journal:  Front Microbiol       Date:  2022-02-01       Impact factor: 5.640

Review 3.  Centralised or Localised Pathogen Whole Genome Sequencing: Lessons Learnt From Implementation in a Clinical Diagnostic Laboratory.

Authors:  Alicia G Beukers; Frances Jenkins; Sebastiaan J van Hal
Journal:  Front Cell Infect Microbiol       Date:  2021-05-18       Impact factor: 5.293

4.  Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.

Authors:  Kate E Wardenburg; Robert F Potter; Alaric W D'Souza; Tahir Hussain; Meghan A Wallace; Saadia Andleeb; Carey-Ann D Burnham; Gautam Dantas
Journal:  J Antimicrob Chemother       Date:  2019-12-01       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.